AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 29888938
Drug: Hypnotic suggestion
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic suggestion for thought insertion
Trial: 21828036
Drug: Mometasone furoate/formoterol
RxNorm normalized name: mometasone furoate/formoterol fumarate 100/5 MCG/INHAL Metered Dose Inhaler, 60 Actuations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mometasone furoate/formoterol (MF/F) 100/10 μg b.i.d.
Trial: 22334769
Drug: Formoterol (F)
DrugBank: Formoterol (DB00983)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Formoterol (F) 10 μg
Trial: 26086920
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg IVTA
Trial: 18463518
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg IVTA
Trial: 18463518
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg IVTA
Trial: 12448658
Drug: Arm B:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arm B: 120 microg/m2 bryostatin-1 given as a 72 hour continuous infusion every 2 weeks
Trial: 7852514
Drug: Oral pamidronate,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral pamidronate, 150 mg/day for at least 5 years
Trial: 10390000
Drug: Oral pamidronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral pamidronate
Trial: 2892450
Drug: Cetirizine 5
RxNorm normalized name: cetirizine 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine 5 mg
Trial: 25829456
Drug: TIMA (Texas
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TIMA (Texas Implementation of Medication Algorithm)
Trial: 20849715
Drug: Probiotics (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotics (0.25 g, twice daily)
Trial: 2848432
Drug: RIT 4237
RxNorm normalized name: measles virus vaccine live, attenuated Schwarz strain / mumps virus vaccine live, RIT-4385 strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injection [Priorix]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RIT 4237 live attenuated bovine rotavirus vaccine
Trial: 27811070
Drug: Tiotropium 2.5
RxNorm normalized name: TIOTROPIUM 2.5MCG/ACTUAT 60D ORAL INHL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 2.5 µg
Trial: 10634336
Drug: Triple drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple drug (zidovudine, lamivudine, and indinavir)
Trial: 10634336
Drug: Triple drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple drug cases
Trial: 19950739
Drug: Midazolam 50
RxNorm normalized name: midazolam 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 50 microg/kg plus Dexamethasone 0.5 mg/kg
Trial: 17307170
Drug: Asoprisnil 5
RxNorm normalized name: Asoprisnil
DrugBank: Asoprisnil (DB06680)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Asoprisnil 5 mg
Trial: 31777761
Drug: Asoprisnil 10
RxNorm normalized name: Asoprisnil
DrugBank: Asoprisnil (DB06680)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Asoprisnil 10 mg
Trial: 10331682
Drug: Right-sided amobarbital
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Right-sided amobarbital injection
Trial: 8768841
Drug: Oral conjugated
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral conjugated estrogen (1.25 mg daily)
Trial: 8768841
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol (100 micrograms/day)
Trial: 8768841
Drug: GHRH administration
RxNorm normalized name: GHRH(1-44)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GHRH administration after oral estrogens
Trial: 7039841
Drug: Single daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single daily dose of methyldopa
Trial: 7039841
Drug: Multiple daily
RxNorm normalized name: Multivitamin Oral Tablet [MULTIPLE DAILY W/BETA]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple daily dose of methyldopa
Trial: 6124760
Drug: Biosynthetic human
RxNorm normalized name: Proinsulin biosynthetic human
DrugBank: Proinsulin human (DB17875)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biosynthetic human insulin (BHI)
Trial: 27589542
Drug: Placebo and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo and inhaled nitric oxide (iNO)
Trial: 20056373
Drug: Breast pumping
RxNorm normalized name: chicken breast preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breast pumping 0.6h after drinking a 0.4g/kg dose of alcohol (pumped after group)
Trial: 21677574
Drug: Atorvastatin 80
RxNorm normalized name: atorvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 80 mg/d
Trial: 10855852
Drug: Local-regional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local-regional therapy alone for patients with low TLI tumors
Trial: 26632520
Drug: Methotrexate (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methotrexate (25 mg/wk)
Trial: 24650819
Drug: Alcohol (target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (target dose: .08 mg/kg)
Trial: 22770549
Drug: Amiodarone 300
RxNorm normalized name: amiodarone 300 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone 300 mg
Trial: 19521294
Drug: Lidocaine 1.5
RxNorm normalized name: LIDOCAINE 1.5%/EPI 1:200000 INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 1.5 mg/kg
Trial: 2582711
Drug: Ranitidine 50
RxNorm normalized name: ranitidine 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 50 mg every 8 hours
Trial: 8252888
Drug: Ranitidine 6.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 6.25 mg/hr continuous infusion
Trial: 2582711
Drug: Ranitidine 10
RxNorm normalized name: ranitidine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 10 mg/hr continuous infusion
Trial: 186417
Drug: No immunotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No immunotherapy (control group).
Trial: 186417
Drug: Immunotherapy groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy groups (general).
Trial: 186417
Drug: Immunotherapy groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy groups (large-cell anaplastic carcinoma).
Trial: 186417
Drug: Immunotherapy groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy groups (small-cell anaplastic carcinoma).
Trial: 20095330
Drug: VitB2 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VitB2 5 mg, VitC 200 mg, GPC capsule 50 mg, once every other day and VitA capsules 25,000 units weekly during sea-voyage
Trial: 21679264
Drug: Naltrexone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone (50 mg/day)
Trial: 11707638
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment (education and relaxation)
Trial: 9141923
Drug: ORG 9487
RxNorm normalized name: ORG-34517
DrugBank: ORG-34517 (DB05423)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ORG 9487 (1.5-2.0 mg/kg)
Trial: 7702805
Drug: Low sodium
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low sodium diet (20 mmol) with insulin dose of 0.8 mU/min
Trial: 3124676
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of 10 micrograms.kg-1.h-1 naloxone after a 400 micrograms bolus (group F + N)
Trial: 24529119
Drug: Usual salt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual salt diet (9 g/day)
Trial: 27541373
Drug: HPV-16/18 AS04-adjuvanted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV-16/18 AS04-adjuvanted vaccine
Trial: 17414241
Drug: IM lorazepam
RxNorm normalized name: Lorazepam
DrugBank: Lorazepam (DB00186)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IM lorazepam 2 mg
Trial: 17414241
Drug: All active
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All active treatments (IM aripiprazole 9.75 mg, 15 mg, IM lorazepam)
Trial: 2649413
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg of hyoscine intravenously before acid infusion
Trial: 861131
Drug: Labetalol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labetalol (400 mg)
Trial: 31525451
Drug: Mechanical debridement
RxNorm normalized name: PIPERONYL BUTOXIDE TECHNICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mechanical debridement with adjunct antimicrobial photodynamic therapy (MD + aPDT)
Trial: 27597661
Drug: MyoSure Lite
RxNorm normalized name: Lite 'N Foamy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MyoSure Lite (ML)
Trial: 17299471
Drug: Oral methionine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral methionine (0.17 mmol/kg body weight) with oral iron (ferrous sulfate, 13 mumol/kg)
Trial: 17299471
Drug: Oral methionine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral methionine (0.17 mmol/kg body weight) without oral iron
Trial: 11607883
Drug: SRL treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRL treatment (30 mg every 14 days for 3 months, then every 10 days until 6 months)
Trial: 11607883
Drug: SRL treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRL treatment before surgery
Trial: 7811540
Drug: Switching to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Switching to didanosine after prior zidovudine therapy
Trial: 3217412
Drug: Caffeine 8
RxNorm normalized name: caffeine 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine 8 mg/kg
Trial: 26232692
Drug: Diclofenac suppository
RxNorm normalized name: diclofenac Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac suppository 2 hours before biopsy + 10 mL of 2% Xylocaine gel 5 minutes before biopsy
Trial: 26232692
Drug: Xylocaine gel
RxNorm normalized name: Xylocaine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Xylocaine gel only
Trial: 23116363
Drug: SCH 900435
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 900435 8 mg
Trial: 23116363
Drug: SCH 900435
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 900435 12 mg
Trial: 23116363
Drug: SCH 900435
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 900435 20 mg
Trial: 23116363
Drug: SCH 900435
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 900435 30 mg
Trial: 23116363
Drug: Multiple ascending
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple ascending dose study
Trial: 14743096
Drug: Extubation relayed
RxNorm normalized name: Latanoprost related compound e
DrugBank: Latanoprost acid (DB19360)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extubation relayed by nasal oxygen therapy (group B)
Trial: 23279632
Drug: doubling baseline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: doubling baseline statin (simvastatin 40 mg or atorvastatin 20 mg)
Trial: 7862216
Drug: Paclitaxel 175
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 175 mg/m2
Trial: 6433769
Drug: HB 420
RxNorm normalized name: Citalopram Hydrobromide
DrugBank: Citalopram (DB00215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: HB 420 (3.5 mg)
Trial: 30067074
Drug: GS100 (nonsystemic,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GS100 (nonsystemic, orally administered hydrogel) co-administered with metformin
Trial: 16873952
Drug: Standard antiasthmatic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antiasthmatic therapy
Trial: 11904108
Drug: Thyroxine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyroxine treatment (50 to 100 microg daily)
Trial: 8970936
Drug: Thyroxine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyroxine treatment
Trial: 10453443
Drug: Selected vegetables
RxNorm normalized name: Hydrogenated Vegetable Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selected vegetables (SV) added to the daily diet of stage III and IV NSCLC patients (SVG group).
Trial: 2083404
Drug: Choline magnesium
RxNorm normalized name: Choline Magnesium Trisalicylate
DrugBank: Choline (DB00122)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Choline magnesium trisalicylate (CMT, trilisate) pre-treatment at a dose of 3000 mg daily for 3 days
Trial: 7459899
Drug: High-dose cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose cyclophosphamide (CTX)
Trial: 31605663
Drug: Exercise training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise training (3 months of supervised aerobic and resistance exercise training, twice a week for 60 min)
Trial: 17121051
Drug: Shenqi Fuzheng
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenqi Fuzheng Injection (SFI)
Trial: 19463378
Drug: Heparin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin plus GP IIb/IIIa inhibitor (control) (n = 317)
Trial: 10753259
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A therapy
Trial: 25097088
Drug: Lidocaine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (50 mg)
Trial: 25097088
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate (0.25 mg)
Trial: 25097088
Drug: Lidocaine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (50 mg) plus Magnesium sulfate (0.25 mg)
Trial: 23051680
Drug: Home unattended
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Home unattended portable monitoring and automatic CPAP titration
Trial: 21743432
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (n=19) - received customary training in oral diagnosis
Trial: 18231111
Drug: Transitions between
RxNorm normalized name: CONNECTOR,ENFIT TRANSITIONAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transitions between phases of treatment
Trial: 14587168
Drug: Lytic or
RxNorm normalized name: pepsin/enzymes,digestive/whole bile/enzymes, proteolytic ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lytic or combination therapy for patients less than 75 years of age in hospitals unable to perform early PCI.
Trial: 14587168
Drug: Fibrinolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrinolytic therapy for patients older than 75 years unable to receive early PCI.
Trial: 14587168
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy using IIb/IIIa inhibitors plus fibrinolytics and/or LMWH.
Trial: 8790090
Drug: Oral acyclovir,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral acyclovir, 400 mg, 5 times daily
Trial: 6090019
Drug: Ceftizoxime (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftizoxime (2 gm/day, administered intravenously)
Trial: 30878496
Drug: Robotic-assisted shoulder
RxNorm normalized name: Head & Shoulders
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Robotic-assisted shoulder rehabilitation therapy (30 minutes per day, 5 times per week for 4 weeks)
Trial: 30866621
Drug: Conventional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physical therapy
Trial: 30541622
Drug: Pre-cognitive behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-cognitive behavioural therapy digital 'informed choice' intervention
Trial: 27653444
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg per day of azathioprine (AZA)
Trial: 27653444
Drug: 2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg/kg per day of azathioprine (AZA)
Trial: 16007042
Drug: Framon (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Framon (0.25 mg/kg, intravenous bolus)
Trial: 8964631
Drug: Bioelectrical impedance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bioelectrical impedance analysis (BIA) at the end of treatment
Trial: 7631946
Drug: 2% glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% glucose in lactated Ringer's solution (D2LR)
Trial: 7631946
Drug: 5% glucose
RxNorm normalized name: Dextrose/Water 5% Oral Solution [ENFAMIL 5% GLUCOSE IN WATER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% glucose in lactated Ringer's solution (D5LR)
Trial: 2042756
Drug: Lactated Ringer's
RxNorm normalized name: LACTATED RINGER'S
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactated Ringer's solution alone (LR)
Trial: 28914978
Drug: Dichloroacetate (DCA)
RxNorm normalized name: dichloroacetate
DrugBank: Sodium dichloroacetate (DB16929)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dichloroacetate (DCA) 12.5 mg/kg twice daily for EGT carrier children
Trial: 28914978
Drug: Dichloroacetate (DCA)
RxNorm normalized name: dichloroacetate
DrugBank: Sodium dichloroacetate (DB16929)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dichloroacetate (DCA) 10.6 mg/kg twice daily for EGT noncarrier children
Trial: 27102361
Drug: Curcumin (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin (1500 mg/d BiocurcumaxTM)
Trial: 28313
Drug: Triazolam 0.5
RxNorm normalized name: triazolam 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam 0.5 mg (Halcion)
Trial: 28075066
Drug: Alogliptin +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alogliptin + Metformin FDC (12.5 mg + 500 mg BID)
Trial: 28075066
Drug: Alogliptin (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alogliptin (12.5 mg BID)
Trial: 28394459
Drug: Metformin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (500 mg BID)
Trial: 11185668
Drug: Pilocarpine (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pilocarpine (single oral doses ranging from 2.5 to 20 mg)
Trial: 6188892
Drug: Pirmenol (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirmenol (150 mg/30 min)
Trial: 6188892
Drug: Lidocaine (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (250 mg/30 min)
Trial: 26856226
Drug: Edoxaban 60/30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxaban 60/30 mg
Trial: 19127595
Drug: Rasagiline (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rasagiline (1 mg/day)
Trial: 15856079
Drug: Sertraline or
RxNorm normalized name: sertraline Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline or bupropion treatment for 5 weeks
Trial: 11991878
Drug: Inhaled substance
RxNorm normalized name: Inhalation Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled substance P
Trial: 11991878
Drug: Inhaled neurokinin
RxNorm normalized name: Neurokinin p
DrugBank: Substance P (DB19198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled neurokinin A (Control)
Trial: 19635615
Drug: BZA (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BZA (20 mg)/CE (0.625 or 0.45 mg)
Trial: 15242359
Drug: Naftopidil (50-75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naftopidil (50-75 mg daily)
Trial: 15242359
Drug: Eviprostat (six
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eviprostat (six tablets daily)
Trial: 11760371
Drug: Interferon alfa
RxNorm normalized name: Interferon alfa
DrugBank: Interferon alfa (DB05258)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa 5 million units thrice weekly plus oral ribavirin 1,200 mg daily for 24 weeks (regimen A)
Trial: 11760371
Drug: Interferon alfa
RxNorm normalized name: Interferon alfa
DrugBank: Interferon alfa (DB05258)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa 5 million units thrice weekly plus oral ribavirin 1,200 mg daily for 24 weeks followed by interferon alfa 3 MU thrice weekly for another 24 weeks (regimen B)
Trial: 9531230
Drug: Esterified estrogens
RxNorm normalized name: Esterified Estrogens
DrugBank: Esterified estrogens (DB09381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esterified estrogens 0.3 mg/d
Trial: 9531230
Drug: Esterified estrogens
RxNorm normalized name: Esterified Estrogens
DrugBank: Esterified estrogens (DB09381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esterified estrogens 0.625 mg/d
Trial: 9531230
Drug: Esterified estrogens
RxNorm normalized name: Esterified Estrogens
DrugBank: Esterified estrogens (DB09381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esterified estrogens 1.25 mg/d
Trial: 26196502
Drug: Daclatasvir (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daclatasvir (60 mg daily) plus Sofosbuvir (400 mg daily) for 12 weeks
Trial: 26196502
Drug: Daclatasvir (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daclatasvir (60 mg daily) plus Sofosbuvir (400 mg daily) for 8 weeks
Trial: 16612142
Drug: Hydroalcoholic gels
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroalcoholic gels containing ibuprofen
Trial: 12802750
Drug: IFN‐alpha‐2b monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN‐alpha‐2b monotherapy (10 million U 3 times per week for 12 months)
Trial: 11199949
Drug: Opipramol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Opipramol (200 mg/day)
Trial: 1386490
Drug: Perindopril (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril (4 to 8 mg daily)